loadpatents
name:-0.021848917007446
name:-0.0054798126220703
name:-0.014185905456543
Tojo; Shingo Patent Filings

Tojo; Shingo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tojo; Shingo.The latest application filed is for "1,4-disubstituted imidazole derivative".

Company Profile
7.5.13
  • Tojo; Shingo - Osaka JP
  • Tojo; Shingo - Osaka-shi JP
  • Tojo; Shingo - Osaka-fu JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
1,4-disubstituted Imidazole Derivative
App 20210171440 - Ban; Hitoshi ;   et al.
2021-06-10
Imidazolylamide derivative
Grant 10,898,469 - Ban , et al. January 26, 2
2021-01-26
1,4-disubstituted imidazole derivative
Grant 10,807,945 - Ban , et al. October 20, 2
2020-10-20
Substituted purine derivative
Grant 10,703,755 - Tojo , et al.
2020-07-07
3-(aryl Or Heteroaryl) Methyleneindolin-2-one Derivatives As Inhibitors Of Cancer Stem Cell Pathway Kinases For The Treatment Of
App 20190241569 - Li; Chiang Jia ;   et al.
2019-08-08
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative
App 20190241550 - Tsuboi; Katsunori ;   et al.
2019-08-08
Substituted Purine Derivative
App 20190169191 - TOJO; Shingo ;   et al.
2019-06-06
Imidazolylamide Derivative
App 20190060282 - Ban; Hitoshi ;   et al.
2019-02-28
1,4-disubstituted Imidazole Derivative
App 20180230085 - Ban; Hitoshi ;   et al.
2018-08-16
1,4-disubstituted imidazole derivative
Grant 9,828,362 - Ban , et al. November 28, 2
2017-11-28
1,4-disubstituted Imidazole Derivative
App 20170166552 - Ban; Hitoshi ;   et al.
2017-06-15
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative
App 20160075697 - Tsuboi; Katsunori ;   et al.
2016-03-17
3-(aryl Or Heteroaryl) Methyleneindolin-2-one Derivatives As Inhibitors Of Cancer Stem Cell Pathway Kinases For The Treatment Of Cancer
App 20160031888 - Li; Chiang Jia ;   et al.
2016-02-04
Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
Grant 9,227,962 - Tsuboi , et al. January 5, 2
2016-01-05
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative
App 20140275076 - Tsuboi; Katsunori ;   et al.
2014-09-18
Novel Compounds
App 20110136801 - Isobe; Yoshiaki ;   et al.
2011-06-09
Purine Derivatives For The Treatment Of Viral Or Allergic Diseases And Cancers
App 20090082332 - Abbot; Philip ;   et al.
2009-03-26
Novel Adenine Compound
App 20080269240 - Hashimoto; Kazuki ;   et al.
2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed